Ergebnisse für *

Zeige Ergebnisse 1 bis 2 von 2.

  1. Mycobacterium chimaera Pulmonary Disease in Cystic Fibrosis Patients, France, 2010–2017
    Erschienen: 2019
    Verlag:  HAL CCSD ; Centers for Disease Control and Prevention

    International audience mehr

     

    International audience

     

    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
    Quelle: BASE Fachausschnitt AVL
    Sprache: Englisch
    Medientyp: Aufsatz aus einer Zeitschrift
    Format: Online
    Übergeordneter Titel: ISSN: 1080-6040 ; EISSN: 1080-6059 ; Emerging Infectious Diseases ; https://hal.science/hal-02069924 ; Emerging Infectious Diseases, 2019, 25 (3), pp.611-613. ⟨10.3201/eid2503.181590⟩
    Schlagworte: respiratory infections; tuberculosis and other mycobacteria; France; Mycobacterium avium complex; Mycobacterium chimaera; NTM; bacteria; cystic fibrosis; forced expiratory volume; forced vital capacity; nontuberculosis mycobacteria; pulmonary disease; [SDV]Life Sciences [q-bio]
    Lizenz:

    info:eu-repo/semantics/OpenAccess

  2. Multicenter Retrospective Study of Vascular Infections and Endocarditis Caused by Campylobacter spp., France

    The incidence of campylobacteriosis has substantially increased over the past decade, notably in France. Secondary localizations complicating invasive infections are poorly described. We aimed to describe vascular infection or endocarditis caused by... mehr

     

    The incidence of campylobacteriosis has substantially increased over the past decade, notably in France. Secondary localizations complicating invasive infections are poorly described. We aimed to describe vascular infection or endocarditis caused by Campylobacter spp. We included 57 patients from a nationwide 5-year retrospective study on Campylobacter spp. bacteremia conducted in France; 44 patients had vascular infections, 12 had endocarditis, and 1 had both conditions. Campylobacter fetus was the most frequently involved species (83%). Antibiotic treatment involved a β-lactam monotherapy (54%) or was combined with a fluoroquinolone or an aminoglycoside (44%). The mortality rate was 25%. Relapse occurred in 8% of cases and was associated with delayed initiation of an efficient antimicrobial therapy after the first symptoms, diabetes, and coexistence of an osteoarticular location. Cardiovascular Campylobacter spp. infections are associated with a high mortality rate. Systematically searching for those localizations in cases of C. fetus bacteremia may be warranted.

     

    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
    Quelle: BASE Fachausschnitt AVL
    Sprache: Englisch
    Medientyp: Aufsatz aus einer Zeitschrift
    Format: Online
    Übergeordneter Titel: ISSN: 1080-6040 ; EISSN: 1080-6059 ; Emerging Infectious Diseases ; https://univ-fcomte.hal.science/hal-04225854 ; Emerging Infectious Diseases, 2023, 29 (3), pp.484-492. ⟨10.3201/eid2903.221417⟩
    Schlagworte: Campylobacter spp; France; bacteria; bacterial infections; graft infections; infectious aortitis; non-HACEK endocarditis; thrombophlebitis; MESH: Humans; MESH: Retrospective Studies; MESH: Endocarditis; MESH: Campylobacter fetus; MESH: Campylobacter Infections; MESH: Anti-Bacterial Agents; MESH: Bacteremia; MESH: France; MESH: Campylobacter; MESH: Multicenter Studies as Topic; [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
    Lizenz:

    info:eu-repo/semantics/OpenAccess